Sign inGet started

TRAW

Traws Pharma, Inc.CIK 1130598 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
14

AI insights for TRAW PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for TRAW
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Parker Charles NolanChief Financial Officer5$0$02026-07-09
Redfield RobertChief Medical Officer6$0$02026-07-09
Pauza Charles DavidChief Science Officer Virology8$0$02026-07-09
Savchuk NikolayChief Operating Officer18$0$02026-07-09
Clarke TraffordDirector6$0$02026-07-09
Shoemaker Mary TeresaDirector6$0$02026-07-09
Dukes Iain D.Executive Chairman12$0$02026-07-09
Leaman John HaroldDirector6$0$02026-07-09
CAUTREELS WERNERDirector11$0$02026-07-09
STOVER JACK EDirector6$0$02026-07-09
OrbiMed Capital GP VIII LLC10% Owner6$998.2K$02026-04-16
TPAV, LLC10% Owner2$0$02024-12-29
Greenwood LubaDirector1$0$02024-09-16
Guerin Mark PatrickCFO3$0$02024-06-18

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Leaman John HaroldDirector A Award deriv2026-07-092026-07-1414,150— $014,150SEC↗
Clarke TraffordDirector A Award deriv2026-07-092026-07-1414,150— $014,150SEC↗
Shoemaker Mary TeresaDirector A Award deriv2026-07-092026-07-1414,150— $014,150SEC↗
Parker Charles NolanChief Financial Officer A Award deriv2026-07-092026-07-1490,000— $090,000SEC↗
Redfield RobertChief Medical Officer A Award deriv2026-07-092026-07-1484,000— $084,000SEC↗
Dukes Iain D.Chief Executive Officer A Award deriv2026-07-092026-07-14274,000— $0274,000SEC↗
STOVER JACK EDirector A Award deriv2026-07-092026-07-1414,150— $014,150SEC↗
Savchuk NikolayChief Operating Officer A Award deriv2026-07-092026-07-1593,000— $093,000SEC↗
CAUTREELS WERNERDirector A Award deriv2026-07-092026-07-1514,150— $014,150SEC↗
Pauza Charles DavidChief Science Officer Virolo A Award deriv2026-07-092026-07-1697,000— $097,000SEC↗
OrbiMed Capital GP VIII LLC10% Owner P Buy deriv2026-04-162026-04-28597,729— $0597,729SEC↗
OrbiMed Capital GP VIII LLC10% Owner P Buy deriv2026-04-162026-04-28597,729— $0597,729SEC↗
OrbiMed Capital GP VIII LLC10% Owner P Buy deriv2026-04-162026-04-281,793,187— $01,793,187SEC↗
OrbiMed Capital GP VIII LLC10% Owner P Buy2026-04-162026-04-28597,729$1.67 $998.2K1,203,250SEC↗
Parker Charles NolanChief Financial Officer A Award deriv2026-03-082026-04-08104,544— $0104,544SEC↗
Shoemaker Mary TeresaDirector A Award deriv2026-03-082026-03-1033,435— $033,435SEC↗
Redfield RobertChief Medical Officer A Award deriv2026-03-082026-03-10108,854— $0108,854SEC↗
STOVER JACK EDirector A Award deriv2026-03-082026-03-1033,435— $033,435SEC↗
Savchuk NikolayChief Operating Officer A Award deriv2026-03-082026-03-1096,899— $096,899SEC↗
Pauza Charles DavidChief Science Officer Virolo A Award deriv2026-03-082026-03-10118,367— $0118,367SEC↗
Dukes Iain D.Chief Executive Officer A Award deriv2026-03-082026-03-10231,336— $0231,336SEC↗
Leaman John HaroldDirector A Award deriv2026-03-082026-03-1033,435— $033,435SEC↗
CAUTREELS WERNERDirector A Award deriv2026-03-082026-03-1031,258— $031,258SEC↗
Clarke TraffordDirector A Award deriv2026-03-082026-03-1033,435— $033,435SEC↗
Parker Charles NolanChief Financial Officer A Award deriv2025-12-122026-04-0861,571— $061,571SEC↗
Parker Charles NolanChief Financial Officer A Award2025-12-122026-04-0815,393— $015,393SEC↗
Savchuk NikolayChief Operating Officer A Award deriv2025-12-122025-12-1665,676— $065,676SEC↗
Redfield RobertChief Medical Officer A Award deriv2025-12-122025-12-1665,676— $065,676SEC↗
Pauza Charles DavidChief Science Officer Virolo A Award deriv2025-12-122025-12-1673,886— $073,886SEC↗
Dukes Iain D.Chief Executive Officer A Award deriv2025-12-122025-12-16147,771— $0147,771SEC↗
STOVER JACK EDirector A Award deriv2025-12-122025-12-1624,629— $024,629SEC↗
Shoemaker Mary TeresaDirector A Award deriv2025-12-122025-12-1624,629— $024,629SEC↗
CAUTREELS WERNERDirector A Award deriv2025-12-122025-12-1619,496— $019,496SEC↗
Clarke TraffordDirector A Award deriv2025-12-122025-12-1624,629— $024,629SEC↗
Leaman John HaroldDirector A Award deriv2025-12-122025-12-1616,234— $016,234SEC↗
Savchuk NikolayChief Operating Officer A Award2025-12-122025-12-1616,419— $0150,606SEC↗
Redfield RobertChief Medical Officer A Award2025-12-122025-12-1616,419— $0113,919SEC↗
Pauza Charles DavidChief Science Officer Virolo A Award2025-12-122025-12-1618,471— $0115,971SEC↗
Dukes Iain D.Chief Executive Officer A Award2025-12-122025-12-1636,943— $0171,130SEC↗
STOVER JACK EDirector A Award2025-12-122025-12-166,157— $06,165SEC↗
Shoemaker Mary TeresaDirector A Award2025-12-122025-12-166,157— $06,292SEC↗
CAUTREELS WERNERDirector A Award2025-12-122025-12-164,874— $0109,222SEC↗
Clarke TraffordDirector A Award2025-12-122025-12-166,157— $06,157SEC↗
Leaman John HaroldDirector A Award2025-12-122025-12-164,058— $04,058SEC↗
Leaman John HaroldDirector A Award deriv2025-11-212025-11-2512,770— $012,770SEC↗
Parker Charles NolanChief Financial Officer A Award deriv2025-10-122026-04-0832,406— $032,406SEC↗
Shoemaker Mary TeresaDirector A Award deriv2025-10-122025-10-1511,530— $011,530SEC↗
Clarke TraffordDirector A Award deriv2025-10-122025-10-1511,530— $011,530SEC↗
STOVER JACK EDirector A Award deriv2025-10-122025-10-1511,530— $011,530SEC↗
CAUTREELS WERNERDirector A Award deriv2025-10-122025-10-1511,530— $011,530SEC↗
Dukes Iain D.Chief Executive Officer A Award deriv2025-10-122025-10-1564,839— $064,839SEC↗
Pauza Charles DavidChief Science Officer Virolo A Award deriv2025-10-122025-10-1532,406— $032,406SEC↗
Redfield RobertChief Medical Officer A Award deriv2025-10-122025-10-1532,406— $032,406SEC↗
Savchuk NikolayChief Operating Officer A Award deriv2025-10-122025-10-1522,435— $022,435SEC↗
Leaman John HaroldDirector A Award deriv2025-10-012025-10-1415,609— $015,609SEC↗
CAUTREELS WERNERDirector A Award deriv2025-06-192025-06-2323,000— $023,000SEC↗
Shoemaker Mary TeresaDirector A Award deriv2025-06-192025-06-2323,000— $023,000SEC↗
STOVER JACK EDirector A Award deriv2025-06-192025-06-2323,000— $023,000SEC↗
Clarke TraffordDirector A Award deriv2025-06-192025-06-2323,000— $023,000SEC↗
Savchuk NikolayChief Operating Officer J Other deriv2025-04-022025-04-082,264— $00SEC↗
Savchuk NikolayChief Operating Officer J Other2025-04-022025-04-08605,531— $00SEC↗
CAUTREELS WERNERChief Executive Officer M Exercise deriv2025-02-182025-02-1996,348— $00SEC↗
CAUTREELS WERNERChief Executive Officer M Exercise2025-02-182025-02-1996,348$0.01 $963104,348SEC↗
Savchuk NikolayChief Operating Officer P Buy deriv2024-12-292025-01-2796,348— $096,348SEC↗
Savchuk NikolayChief Operating Officer P Buy deriv2024-12-292025-01-2796,348— $096,348SEC↗
TPAV, LLC10% Owner P Buy deriv2024-12-292025-01-2796,348— $096,348SEC↗
TPAV, LLC10% Owner P Buy deriv2024-12-292025-01-2796,348— $096,348SEC↗
CAUTREELS WERNERChief Executive Officer P Buy deriv2024-12-292025-01-2796,348— $096,348SEC↗
CAUTREELS WERNERChief Executive Officer P Buy deriv2024-12-292025-01-2796,348— $096,348SEC↗
OrbiMed Capital GP VIII LLC10% Owner P Buy deriv2024-12-292025-01-2796,348— $096,348SEC↗
OrbiMed Capital GP VIII LLC10% Owner P Buy deriv2024-12-292025-01-2796,348— $096,348SEC↗
Greenwood LubaDirector A Award deriv2024-09-162024-09-17164,000— $0164,000SEC↗
Guerin Mark PatrickCFO M Exercise deriv2024-06-182024-06-205,500— $05,500SEC↗
Guerin Mark PatrickCFO F Tax w/h2024-06-182024-06-202,221$0.47 $1.0K39,255SEC↗
Guerin Mark PatrickCFO M Exercise2024-06-102024-06-205,500— $041,476SEC↗
Savchuk NikolayChief Operating Officer A Award2024-04-012024-08-0767,500— $0134,187SEC↗
Dukes Iain D.Executive Chairman A Award2024-04-012024-08-0767,500— $0134,187SEC↗
Dukes Iain D.Executive Chairman A Award deriv2024-04-012024-04-033,802,890— $03,802,890SEC↗
Dukes Iain D.Executive Chairman A Award deriv2024-04-012024-04-034,801— $04,801SEC↗
Dukes Iain D.Executive Chairman A Award deriv2024-04-012024-04-03195— $0195SEC↗
Savchuk NikolayChief Operating Officer A Award deriv2024-04-012024-04-033,802,890— $03,802,890SEC↗
Savchuk NikolayChief Operating Officer A Award deriv2024-04-012024-04-034,801— $04,801SEC↗
Savchuk NikolayChief Operating Officer A Award deriv2024-04-012024-04-032,584— $02,584SEC↗
Savchuk NikolayChief Operating Officer A Award deriv2024-04-012024-04-03195— $0195SEC↗
Pauza Charles DavidChief Science Officer Virolo A Award deriv2024-04-012024-04-03333,136— $0333,136SEC↗
Pauza Charles DavidChief Science Officer Virolo A Award deriv2024-04-012024-04-03503,227— $0503,227SEC↗
Dukes Iain D.Executive Chairman A Award2024-04-012024-04-0366,687— $066,687SEC↗
Dukes Iain D.Executive Chairman A Award2024-04-012024-04-0367,550— $0134,187SEC↗
Dukes Iain D.Executive Chairman A Award2024-04-012024-04-031,645,100— $01,645,100SEC↗
Savchuk NikolayChief Operating Officer A Award2024-04-012024-04-0367,550— $0134,187SEC↗
Savchuk NikolayChief Operating Officer A Award2024-04-012024-04-0366,687— $066,687SEC↗
Savchuk NikolayChief Operating Officer A Award2024-04-012024-04-031,645,100— $01,645,100SEC↗
Savchuk NikolayChief Operating Officer A Award2024-04-012024-04-03885,532— $0885,532SEC↗
CAUTREELS WERNERChief Executive Officer A Award2024-04-012024-04-03200,000— $0200,000SEC↗
Pauza Charles DavidChief Science Officer Virolo A Award2024-04-012024-04-0397,500— $097,500SEC↗
Redfield RobertActing Chief Medical Officer A Award2024-04-012024-04-0397,500— $097,500SEC↗